01702nam a2200349 a 4500001001200000003000800012006001900020007001500039008004100054020001800095020002700113040002100140035002100161050002300182245015200205260003400357300004000391490005000431504005100481505032100532533015200853650002401005650002201029655002901051700002001080700001801100700002301118710001701141830005101158856012601209999001701335ebr10677831CaPaEBRm        u        cr cn|||||||||130403s2013    gw a    sb    001 0 eng d  z9783527332557  z9783527670390 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)84117043014aRC119b.T79 2013eb00aTrypanosomatid diseasesh[electronic resource] :bmolecular routes to drug discovery /cedited by Timo J�ager, Oliver Koch, and Leopold Floh�e.  aWeinheim :bWiley-VCH,c2013.  axxviii, 547 p. :bill. (some col.).1 aDrug discovery in infectious diseases ;vv. 4  aIncludes bibliographical references and index.0 apt. 1. Disease burden, current treatments, medical needs, and strategic approaches -- pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery -- pt. 3. Validation and selection of drug targets in kinetoplasts -- pt. 4. Examples of target-based approaches and compounds under consideration.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aParasitic diseases. 0aTrypanosomatidae. 7aElectronic books.2local1 aJ�ager, Timo.1 aKoch, Oliver.1 aFloh�e, Leopold.2 aebrary, Inc. 0aDrug discovery in infectious diseases ;vv. 4.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10677831zAn electronic book accessible through the World Wide Web; click to view  c59332d59332